Marshall Ken W. 4
4 · Aquestive Therapeutics, Inc. · Filed Dec 3, 2018
Insider Transaction Report
Form 4
Marshall Ken W.
Commercial Leader
Transactions
- Purchase
Common Stock
2018-11-21$10.15/sh+1,445$14,667→ 1,445 total(indirect: See Footnote)
Footnotes (1)
- [F1]Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.